Location: Home
  • search
  • go
  • Relate News
  • 8/7/2024Uncertainty Looms Over Gardasil's Future in China
  • 8/7/2024How to Patent Targeted Therapy Pharmaceuticals in China (IAM)
  • 8/6/2024NHSA's 2023 National BMI Sector Development Report (Thorough Summary)
  • 8/6/2024Buyout of China's Drug Companies by Global Pharma Giants Sparks Nation...
  • 8/6/2024Organon Reports Falling China Sales in Q2/2024 Impacted by VBP
  • 8/6/2024Asymchem Inaugurates New Site in Sandwich, UK
  • 8/6/2024Huadong to Pay $150M for Right to Market ImunoPharm's Novel Anticance...
  • 8/6/2024NMPA Solicits Feedbacks on the Regulations on the Regulation of Export...
  • 8/5/2024BioCity Secures CNY Hundreds of Millions in Series A+ Financing for On...
  • 8/5/2024Snapshot of BMI System Financial Performance in H1/2024
  • 8/5/2024Sihuan Pharma to Distribute Cellontech's Osteoporosis Drug in China
  • 8/5/2024Genmab Assumes Full Ownership of Acasunlimab after BioNTech Exits Part...
  • 8/5/2024CR Sanjiu to Acquire 33% Stake in Tasly Pharma Group for $869M
  • 8/5/2024China Deepens Medical Reform through "Health-first Strategy
  • 8/5/2024Chinese Innovative Drug R&D Trends in 2024: PharmaDJ
  • 8/5/2024Association of Lifestyle with Sleep Health In General Population in Ch...
  • 8/2/2024Nicholas Hall Reports Robust Chinese OTC Analgesics Market Growth in M...
  • 8/2/2024Kyowa Kirin Restructures Asia-Pacific Operations, Sells China Business...
  • 8/2/2024CDE Publicizes the List of Reference Formulations for GQCE Studies (85...
  • 8/2/2024CDE Solicits Public Comments on the Technical Guidelines for Clinical ...
  • 8/2/2024CDE Solicits Comments on the Technical Guidelines for Quality Comparab...
  • 8/2/2024China Sees 124% Surge in Direct Trans-Provincial Medical Bill Settleme...
  • 8/2/2024Recent Official and Executive Moves
  • 8/1/2024Biocytogen and Ideaya Enter License Deal for Potential FIC B7H3/PTK7 T...
  • 8/1/2024Instil Bio and ImmuneOnco Announce License Deal for PD-L1xVEGF BsAb a...
  • 8/1/2024State Council Issues the Guiding Opinions on Improving the Long-term M...
  • 8/1/2024NMPA Accepts NDA for Innovent's T2D Drug Mazdutide
  • 8/1/2024WuXi Biologics Granted EMA Approval for Five Chinese Facilities
  • 7/31/2024Shanghai Unveils Plan to Boost Biopharma R&D
  • 7/31/2024A-Share Listed Companies Report H1/2024 Performance
  • Page:54/774 Total number of articles:23207: [First][<<] [52] [53] [54] [55] [56] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group